Annual accounts
Small accounts
30/09/2026Filing deadline
Made up to 31/12/2024Due 30/09/2026
- Next accounts made up to
- 31/12/2025
- Last accounts made up to
- 31/12/2024
REACTA BIOTECH LIMITED
Active- 08553682Copy
Copy
Registry details
Reference data exactly as held at Companies House.
Copy registry details
- Registered office
- Unit 2 Newtech Square, Deeside Industrial Park, Deeside CH5 2NT
- Classification (SIC)
- Research and experimental development on biotechnology (72.11 - SIC 2007)
- Accounts type
- Small
Company activity
The 4 most recent documents filed at Companies House.
Pre-Score for UK companies is coming soon
- 19/06/2026View PDF (8 pages)
Confirmation statement made on 2026-06-09 with updates
- 04/06/2026View PDF (14 pages)
Resolutions
- 13/03/2026View PDF (2 pages)
Director's details changed for Mr Richard Nagle on 2026-03-13
- 11/03/2026View PDF (2 pages)
Appointment of Mr Richard Nagle as a director on 2026-03-10
Coming soon
What Pre-Score will tell you
- Whether the filed accounts are strengthening or weakening year on year.
- Whether this company files on time, and how often its record changes.
- How its officers and controlling parties connect to other UK companies.
Accounts and confirmation statement
The two filings Companies House requires every year, and where each one stands against its deadline today.
Due in 5 days
Confirmation statement
Confirms the registry record is up to date
- Next statement date
- 09/06/2026
- Last statement dated
- 31/12/2024
Financial performance
The latest figures REACTA BIOTECH LIMITED filed. Okredo holds filed accounts data for 2021–2023; the year-by-year record is on the financials page.
Net Assets
£1.99M2023
368.29%vs 20222022: £424.91K
Total Assets
£4.05M2023
65.96%vs 20222022: £2.44M
Cash in Bank
£861.04K2023
37.98%vs 20222022: £624.03K
Total Liabilities
£1.32M2023
0.53%vs 20222022: £1.31M
Employees
432023
+12vs 20222022: 31
Of the 4 measures with an earlier filing to compare against, 4 rose. Total assets moved furthest, up 65.96% on 2022. See the full financial analysis for REACTA BIOTECH LIMITED.
The full financial record
Four ways through REACTA BIOTECH LIMITED's filed accounts — the year-by-year numbers, the compound rates and the ratios behind them.
Net Assets · +27.9% a year (CAGR)Three-year trend, 2021–2023Every measure end to end across 2021, 2022 and 2023, with the compound rate behind each one.See what moved5 chartsCharts by indicator5 filed indicators plotted year by year, 2021–2023.Plot the figuresNothing estimatedRatios from the filed figures4 ratios computed from this company's own reported amounts, each shown against the year it was derived from.Check the ratios5 × 3 yearsEvery figure by yearAll 5 measures Okredo tracks across 3 reported years, exactly as filed.Open the table
Employees
Headcount as reported to Companies House for 2021–2023.
| Year | Employees | Change |
|---|---|---|
| 2023 | 43 | +12 |
| 2022 | 31 | +15 |
| 2021 | 16 | – |
Reported employee count increased from 16 in 2021 to 43 in 2023. See how headcount moved alongside the reported financials.
Credit report
It is a professional assessment of the company 's performance, revealing company's potential and risks, showing it's past experiences and revealing future prospects.
- Company potential
- Risk indicators
- Past performance
- Future prospects
Officers
15Directors, secretaries and other appointed officers, with the period each has served.
| Person | Role | Period | Connected companies |
|---|---|---|---|
| Director | 29/05/2014–21/10/2022 | 54 | |
| Director | 16/10/2023–Present | 23 | |
| Director | 03/06/2013–22/02/2017 | 21 | |
| Director | 03/06/2013–Present | 6 | |
| Director | 07/07/2021–16/01/2023 | 13 | |
| Director | 18/06/2014–27/10/2016 | 5 | |
| Director | 20/11/2018–Present | 4 | |
| Director | 10/02/2022–Present | 3 | |
| Director | 15/04/2025–Present | 21 | |
| Director | 03/06/2013–01/12/2019 | 0 | |
| Director | 29/04/2016–29/03/2019 | 3 | |
| Director | 20/12/2023–Present | 1 | |
| Director | 10/03/2026–Present | 11 | |
| Director | 15/04/2025–24/06/2025 | 8 | |
| Secretary | 23/10/2023–Present | 0 |
Persons with significant control
4Individuals or entities with significant control over the company, as declared to Companies House.
| Person | Period | Connected companies |
|---|---|---|
| 27/07/2023–Present | 4 | |
| 01/06/2018–Present | 4 | |
| 01/01/2017–21/01/2020 | 6 | |
| 01/01/2017–01/12/2019 | 0 |
Filing history and recent activity
Every document on the Companies House record, newest first.
- Filings on record
- 27 Since 24/10/2022
- Last 12 months
- 4 -3 vs the year before
- Most recent filing
- 19/06/2026 3 months ago
What changed in the last year
- Confirmation statementLatest 19/06/2026
- Officer changes (2)Latest 13/03/2026
Filing timeline
- 19/06/2026View PDF (8 pages)
Confirmation statement made on 2026-06-09 with updates
- 04/06/2026View PDF (14 pages)
Resolutions
- 13/03/2026View PDF (2 pages)
Director's details changed for Mr Richard Nagle on 2026-03-13
- 11/03/2026View PDF (2 pages)
Appointment of Mr Richard Nagle as a director on 2026-03-10
- 24/06/2025View PDF (1 pages)
Termination of appointment of Christopher Guy Weaver as a director on 2025-06-24
- 19/06/2025View PDF (8 pages)
Confirmation statement made on 2025-06-09 with updates
- 18/06/2025View PDF (2 pages)
Notification of Dbw Investments (3) Limited as a person with significant control on 2023-07-27
- 03/06/2025View PDF (18 pages)
Accounts for a small company made up to 2024-12-31
- 08/05/2025View PDF (7 pages)
Registration of charge 085536820003, created on 2025-05-08
- 15/04/2025View PDF (2 pages)
Appointment of Mr Adrian Ivery Field as a director on 2025-04-15
- 15/04/2025View PDF (2 pages)
Appointment of Mr Christopher Guy Weaver as a director on 2025-04-15
- 16/09/2024View PDF (9 pages)
Total exemption full accounts made up to 2023-12-31
Showing 12 of 27 filings
See when the next accounts and confirmation statement are due
Similar companies
4 UK companies are similar to REACTA BIOTECH LIMITED, sharing the same company status (Active), the same industry sector and activity group (Research and experimental development on biotechnology) and a comparable number of employees. The 4 closest matches are shown below to help you compare competitors and industry peers.
CAMBRIDGE GAN DEVICES LIMITED
ActiveJeffreys Building, Suite 8 St Johns Innovation Park, Cowley Road, Cambridge CB4 0DS
- Activity
- Other research and experimental development on natural sciences and engineering
- Company no.
- 10430656
- Incorporated
- 17/10/2016
- Employees
- 49
FIOS GENOMICS LIMITED
ActiveNine, 9 Little France Road, Edinburgh EH16 4UX
- Activity
- Research and experimental development on biotechnology
- Company no.
- SC341432
- Incorporated
- 15/04/2008
- Employees
- 45
SAVA TECHNOLOGIES LTD.
Active117 Charterhouse Street, London EC1M 6AA
- Activity
- Research and experimental development on biotechnology
- Company no.
- 10500092
- Incorporated
- 28/11/2016
- Employees
- 40
XAMPLA LTD
ActiveBio-Innovation Centre, 25 Cambridge Science Park Road, Cambridge CB4 0FW
- Activity
- Other research and experimental development on natural sciences and engineering
- Company no.
- 11637116
- Incorporated
- 23/10/2018
- Employees
- 41
About REACTA BIOTECH LIMITED
A short description of the company, written from its Companies House record.
REACTA BIOTECH LIMITED is a private limited company registered in the United Kingdom, based in Unit 2 Newtech Square, Deeside Industrial Park, Deeside CH5 2NT. Companies House classifies its business as Research and experimental development on biotechnology. It has been on the register for 13 years 3 months.
The register currently records it as active. Its 2023 accounts report net assets of £1.99M and 43 employees.
REACTA BIOTECH LIMITED: frequently asked questions
Answered from this company's own registry record and filed figures.
What does REACTA BIOTECH LIMITED do?
Companies House records REACTA BIOTECH LIMITED under one registered business activity: Research and experimental development on biotechnology (72.11 - SIC 2007).
Is REACTA BIOTECH LIMITED still active?
REACTA BIOTECH LIMITED is recorded as active on the Companies House register, and has been on it since 03/06/2013.
What are REACTA BIOTECH LIMITED's latest reported financials?
The most recent accounts Okredo holds cover 2023 and report net assets of £1.99M, total assets of £4.05M, cash in bank of £861.04K and total liabilities of £1.32M.
When did REACTA BIOTECH LIMITED last file with Companies House?
The most recent document on the record is dated 19/06/2026: Confirmation statement made on 2026-06-09 with updates, 3 months ago.
When are REACTA BIOTECH LIMITED's next filings due?
On the current registry record, accounts are due by 30/09/2026.
Who runs REACTA BIOTECH LIMITED?
Companies House lists 15 officers (8 currently in post) and 4 people with significant control (2 current).